Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes

Science Translational Medicine

Volumn 4, Issue 138, 2012, Pages

  Gottumukkala, Raju V S R K ^a   Lv, HuiJuan ^a   Cornivelli, Lizbeth ^a   Wagers, Amy J ^a,b,c   Kwong, Raymond Y ^a   Bronson, Roderick ^a   Stewart, Garrick C ^a   Schulze, P Christian ^a,d   Chutkow, William ^a   Wolpert, Howard A ^a   Lee, Richard T ^a,c   Lipes, Myra A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Harvard University   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 2; AUTOANTIBODY; MYOSIN HEAVY CHAIN ALPHA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CARDIAC IMAGING; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HELPER CELL; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MYOCARDITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; ANIMAL; HEART MUSCLE; IMMUNOLOGY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 84862547018     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003551     Document Type: Article

References (49)

1. J. R. Brown, G. T. O'Connor, Coronary heart disease and prevention in the United States. N. Engl. J. Med. 362, 2150-2153 (2010).
2. P. Libby, D. M. Nathan, K. Abraham, J. D. Brunzell, J. E. Fradkin, S. M. Haffner, W. Hsueh, M. Rewers, B. T. Roberts, P. J. Savage, S. Skarlatos,M. Wassef, C. Rabadan-Diehl; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus, Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation 111, 3489-3493 (2005).
3. A. M. Secrest, D. J. Becker, S. F. Kelsey, R. E. Laporte, T. J. Orchard, Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 59, 3216-3222 (2010).
4. G. Pambianco, T. Costacou, D. Ellis, D. J. Becker, R. Klein, T. J. Orchard, The 30-year natural history of type 1 diabetes complications: The Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55, 1463-1469 (2006).
5. A. S. Krolewski, E. J. Kosinski, J. H. Warram, O. S. Leland, E. J. Busick, A. C. Asmal, L. I. Rand, A. R. Christlieb, R. F. Bradley, C. R. Kahn, Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am. J. Cardiol. 59, 750-755 (1987).
6. R. F. Hamman, Mortality risk in long-standing type 1 diabetes: Hope and concern. Diabetes 59, 2997-2998 (2010).
7. D. M. Nathan, P. A. Cleary, J. Y. Backlund, S. M. Genuth, J. M. Lachin, T. J. Orchard, P. Raskin, B. Zinman; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353, 2643-2653 (2005).
8. B. Stadinski, J. Kappler, G. S. Eisenbarth, Molecular targeting of islet autoantigens. Immunity 32, 446-456 (2010).
9. J. A. Todd, Etiology of type 1 diabetes. Immunity 32, 457-467 (2010).
10. M. L. Entman, L. Michael, R. D. Rossen, W. J. Dreyer, D. C. Anderson, A. A. Taylor, C. W. Smith, Inflammation in the course of early myocardial ischemia. FASEB J. 5, 2529-2537 (1991).
11. N. G. Frangogiannis, The immune system and cardiac repair. Pharmacol. Res. 58, 88-111 (2008).
12. M. Nahrendorf, M. J. Pittet, F. K. Swirski, Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121, 2437-2445 (2010).
13. J. Zhang, Z. X. Yu, S. Fujita, M. L. Yamaguchi, V. J. Ferrans, Interstitial dendritic cells of the rat heart. Quantitative and ultrastructural changes in experimental myocardial infarction. Circulation 87, 909-920 (1993).
14. S. Gallucci, M. Lolkema, P. Matzinger, Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255 (1999).
15. H. Kono, K. L. Rock, How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289 (2008).
16. A. V. Chervonsky, Influence of microbial environment on autoimmunity. Nat. Immunol. 11, 28-35 (2010).
17. A. Iwasaki, R. Medzhitov, Regulation of adaptive immunity by the innate immune system. Science 327, 291-295 (2010).
18. J. F. Elliott, J. Liu, Z. N. Yuan, N. Bautista-Lopez, S. L. Wallbank, K. Suzuki, D. Rayner, P. Nation, M. A. Robertson, G. Liu, K. M. Kavanagh, Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice. Proc. Natl. Acad. Sci. U.S.A. 100, 13447-13452 (2003).
19. J. A. Taylor, E. Havari, M. F. McInerney, R. Bronson, K. W. Wucherpfennig, M. A. Lipes, A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8. J. Immunol. 172, 2651-2658 (2004).
20. H. Lv, E. Havari, S. Pinto, R. V. Gottumukkala, L. Cornivelli, K. Raddassi, T. Matsui, A. Rosenzweig, R. T. Bronson, R. Smith, A. L. Fletcher, S. J. Turley, K. Wucherpfennig, B. Kyewski, M. A. Lipes, Impaired thymic tolerance to a-myosin directs autoimmunity to the heart in mice and humans. J. Clin. Invest. 121, 1561-1573 (2011).
21. W. Dressler, A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. J. Am. Med. Assoc. 160, 1379-1383 (1956).
22. M. Moraru, A. Roth, G. Keren, J. George, Cellular autoimmunity to cardiac myosin in patients with a recent myocardial infarction. Int. J. Cardiol. 107, 61-66 (2006).
23. S. Göser, M. Andrassy, S. J. Buss, F. Leuschner, C. H. Volz, R. Ottl, S. Zittrich, N. Blaudeck, S. E. Hardt, G. Pfitzer, N. R. Rose, H. A. Katus, Z. Kaya, Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114, 1693-1702 (2006).
24. H. C. Volz, S. J. Buss, J. Li, S. Göser, M. Andrassy, R. Ottl, G. Pfitzer, H. A. Katus, Z. Kaya, Autoimmunity against cardiac troponin I in ischaemia reperfusion injury. Eur. J. Heart Fail. 13, 1052-1059 (2011).
25. U. Nussinovitch, Y. Shoenfeld, The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease. Clin. Rev. Allergy Immunol. 10.1007/s12016-010-8229-8 (2011).
26. R. I. Sherwood, J. L. Christensen, I. M. Conboy, M. J. Conboy, T. A. Rando, I. L.Weissman, A. J. Wagers, Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119, 543-554 (2004).
27. P. J. Bingley, A. J. Williams, Validation of autoantibody assays in type 1 diabetes: Workshop programme. Autoimmunity 37, 257-260 (2004).
28. G. C. Stewart, J. Lopez-Molina, R. V. Gottumukkala, G. F. Rosner, M. S. Anello, J. L. Hecht, G. L. Winters, R. F. Padera, K. L. Baughman, M. A. Lipes, Myocardial parvovirus B19 persistence: Lack of association with clinicopathologic phenotype in adults with heart failure. Circ. Heart Fail. 4, 71-78 (2011).
29. T. Okazaki, Y. Tanaka, R. Nishio, T. Mitsuiye, A. Mizoguchi, J. Wang, M. Ishida, H. Hiai, A. Matsumori, N. Minato, T. Honjo, Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 9, 1477-1483 (2003).
30. S. Eriksson, J. Hellman, K. Pettersson, Autoantibodies against cardiac troponins. N. Engl. J. Med. 352, 98-100 (2005).
31. H. Mahrholdt, U. Sechtem, Noninvasive differentiation between active and healed myocarditis by cardiac magnetic resonance: Are we there yet? JACC Cardiovasc. Imaging 2, 139-142 (2009).
32. D. E. Sosnovik, M. Nahrendorf, N. Deliolanis, M. Novikov, E. Aikawa, L. Josephson, A. Rosenzweig, R. Weissleder, V. Ntziachristos, Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation 115, 1384-1391 (2007).
33. J. L. Gaglia, A. R. Guimaraes, M. Harisinghani, S. E. Turvey, R. Jackson, C. Benoist, D. Mathis, R. Weissleder, Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J. Clin. Invest. 121, 442-445 (2011).
34. M. Lind, I. Bounias, M. Olsson, S. Gudbjornsdottir, A. M. Svensson, A. Rosengren, Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: An observational study. Lancet 378, 140-146 (2011).
35. O. Thaunat, A. C. Field, J. Dai, L. Louedec, N. Patey, M. F. Bloch, C. Mandet, M. F. Belair, P. Bruneval, O. Meilhac, B. Bellon, E. Joly, J. B. Michel, A. Nicoletti, Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response. Proc. Natl. Acad. Sci. U.S.A. 102, 14723-14728 (2005).
36. P. Libby, Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
37. U. Eriksson, R. Ricci, L. Hunziker, M. O. Kurrer, G. Y. Oudit, T. H. Watts, I. Sonderegger, K. Bachmaier, M. Kopf, J. M. Penninger, Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9, 1484-1490 (2003).
38. A. O'Garra, L. Gabryšová, H. Spits, Quantitative events determine the differentiation and function of helper T cells. Nat. Immunol. 12, 288-294 (2011).
39. J. E. Van Eyk, F. Powers, W. Law, C. Larue, R. S. Hodges, R. J. Solaro, Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: Identification of degradation products and effects on the pCa-force relation. Circ. Res. 82, 261-271 (1998).
40. C. E. Ganote, R. S. Vander Heide, Cytoskeletal lesions in anoxic myocardial injury. A conventional and high-voltage electron-microscopic and immunofluorescence study. Am. J. Pathol. 129, 327-344 (1987).
41. D. Frank, C. Kuhn, H. A. Katus, N. Frey, The sarcomeric Z-disc: A nodal point in signalling and disease. J. Mol. Med. 84, 446-468 (2006).
42. A. Abbate, E. Bonanno, A. Mauriello, R. Bussani, G. G. Biondi-Zoccai, G. Liuzzo, A. M. Leone, F. Silvestri, A. Dobrina, F. Baldi, F. Pandolfi, L. M. Biasucci, A. Baldi, L. G. Spagnoli, F. Crea, Widespread myocardial inflammation and infarct-related artery patency. Circulation 110, 46-50 (2004).
43. K. Thygesen, J. S. Alpert, H. D. White; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, A. S. Jaffe, F. S. Apple, M. Galvani, H. A. Katus, L. K. Newby, J. Ravkilde, B. Chaitman, P. M. Clemmensen, M. Dellborg, H. Hod, P. Porela, R. Underwood, J. J. Bax, G. A. Beller, R. Bonow, E. E. Van der Wall, J. P. Bassand,W.Wijns, T. B. Ferguson, P. G. Steg, B. F. Uretsky, D. O. Williams, P. W. Armstrong, E. M. Antman, K. A. Fox, C. W. Hamm, E. M. Ohman, M. L. Simoons, P. A. Poole-Wilson, E. P. Gurfinkel, J. L. Lopez-Sendon, P. Pais, S. Mendis, J. R. Zhu, L. C. Wallentin, F. Fernández-Avilés, K. M. Fox, A. N. Parkhomenko, S. G. Priori, M. Tendera, L. M. Voipio-Pulkki, A. Vahanian, A. J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, J. Morais, S. Brener, R. Harrington, D. Morrow, M. Lim, M. A. Martinez-Rios, S. Steinhubl, G. N. Levine, W. B. Gibler, D. Goff, M. Tubaro, D. Dudek, N. Al-Attar, Universal definition of myocardial infarction. Circulation 116, 2634-2653 (2007).
44. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34 (Suppl. 1), S62-S69 (2011).
45. A. Ducharme, S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, L. E. Rohde, F. J. Schoen, R. A. Kelly, Z. Werb, P. Libby, R. T. Lee, Targeted deletion ofmatrixmetalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106, 55-62 (2000).
46. E. Havari, A. M. Lennon-Dumenil, L. Klein, D. Neely, J. A. Taylor, M. F. McInerney, K. W. Wucherpfennig, M. A. Lipes, Expression of the B7.1 costimulatory molecule on pancreatic β cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes. J. Immunol. 173, 787-796 (2004).
47. I. M. Conboy, M. J. Conboy, A. J. Wagers, E. R. Girma, I. L. Weissman, T. A. Rando, Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760-764 (2005).
48. R. I. Sherwood, J. L. Christensen, I. L. Weissman, A. J. Wagers, Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells 22, 1292-1304 (2004).
49. E. H. Kemp, E. A. Waterman, B. E. Hawes, K. O' Neill, R. V. Gottumukkala, D. J. Gawkrodger, A. P. Weetman, P. F. Watson, The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J. Clin. Invest. 109, 923-930 (2002).